DK172541B1 - Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet - Google Patents
Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet Download PDFInfo
- Publication number
- DK172541B1 DK172541B1 DK198304643A DK464383A DK172541B1 DK 172541 B1 DK172541 B1 DK 172541B1 DK 198304643 A DK198304643 A DK 198304643A DK 464383 A DK464383 A DK 464383A DK 172541 B1 DK172541 B1 DK 172541B1
- Authority
- DK
- Denmark
- Prior art keywords
- chamber
- support
- outlet
- container
- medicament
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims description 48
- 229940079593 drug Drugs 0.000 title claims description 33
- 238000002483 medication Methods 0.000 title description 3
- 239000011888 foil Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 2
- 239000002775 capsule Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000009512 pharmaceutical packaging Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
- A61M2205/6081—Colour codes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Description
DK PR 172541 B1
Opfindelsen vedrører et apparat af den art, der er angivet i krav i'a indledning. Der kendea i dag apparater, ved hjalp af hvilke et medikament kan administreres til eller af patienter ved inhalering genneai apparaterne. Medikamenterne kan have faet, findelt fona eller S vaskeform. Sådanne apparater er ganske velkendte til administrering af medikamenter, som er indeholdt i kapsler, til patienter, der lider af lunge syg doerne, såsom fx bronkial astma. Det er til et swdikament i pulverform eller anden findelt form kendt at frembringe SMdikamentet i kapsler, der af en patient indføres i et sådant apparat, som under-10 tiden kaldes en "insufflator". Medikamentet frigøres derefter fra kapslen og inhaleres af patienten, sadvanligvis gennem munden, men undertiden gennem nasen.
X beskrivelserne til PCT-ansøgning, publikationsnr. W082/01470, og OB patentskrift nr. 1387954 er der beskrevet apparater til afgivelse af IS et medikament i findelt form fra kapsler. I hvert af disse tidligere beskrevne apparater er kapslerne monteret på en drejelig understøt -ningsdel, på hvilken hver kapsel efter tur kan føres til en stilling, i hvilken den åbnes for at suliggøre, at medikamentet kan afgives fra kapslen for at tillade, at det kan inhaleres af en person, som in· 20 halerer gennem apparatets udløb. X det i OB patentskrift nr. 1387954 beskrevne apparat kan kapslerne vare monteret i en såkaldt "blisterpakning" .
Der er imidlertid ulesper forbundet ned brugen af kapsler, der er fremstillet af gelatine, og som indeholder medikamenter. Gelatine er 25 relativt ustabilt og mangler fysisk styrke, så at kapslerne skal beskyttes ved emballering, fx i glasflasker. Miljanedbrydning af både kapslerne og deres indhold kan ske i løbet af relativt kort tid. I GB patentskrift 1075679 beskrives en udleveringsbeholder til medikamenter, hvor medikamentet kan vare i form af enkeltdoser såsom piller, 30 tabletter, kapsler o.l., hvor beholderen omfatter et cirkulert hus med bund, vmgge og et lig. Låget er udført med lommer udformet i et forholdsvis skørt foliemateriale, og de nævnte piller, kapsler o.l er anbragt i disse lommer.
Formålet sted den foreliggende opfindelse er at tilvejebringe en mere 35 bekvem måde til administrering af et medikament til sådanne patien- .'r'OCID: <DK *7?541B > 2 DK PR 172541 B1 ter, end det hidtil har varet muligt, hvorved nødvendigheden af indpakning af medikamenterne i kapsler undgås.
Til opnåelse af formålet tilvejebringes der ifølge den foreliggende opfindelse et apparat til administrering af medikamenter til patien-S ter, hvilket apparat omfatter et hus med et cylindrisk kammer, et luftindløb til kammeret, en understøtning, der er placeret inden i kammeret, og som er indrettet til at understøtte en bareskive med en eller flere beholdere, hvori et medikament er indeholdt, hvilke beholdere er placeret i en cirkel, et stempel, der kan drives til at 10 indgribe med en beholder, der er placeret ud for stemplet, til åbning af beholderen, organer til drejning af en bareskive på understøtningen til anbringelse af beholderen eller hver af disse efter tur ud for stemplet, samt et udløb, der står i forbindelse »ed kammerets indre, og gennem hvilket en patient kan inhalere, hvorved der fra en IS beholder frigives medikament, som føres med i den luftstrøm, der frembringes af patienten, så at medikasientet ledes gennem udløbet, hvilket apparat er ejendomneligt ved, at bareskivens beholdere er udformet i ét med bareskiven, og at understøtningen er indrettet til at holde bareskiven stationer bortset fra drejebevagelsen, idet 20 medikamentet frigøres gennem patientens inhalering fra en åbnet beholder, mens denne er stationer, og hvor understøtningen omfatter en drejelig plade med flere huller der strakker sig gennem pladen, og som er placeret i en cirkel, og hver er indrettet til at optage en beholder med medikament.
2S odløbet er hensigtsmassigt, men ikke nødvendigvis, et mundstykke, gennem hvilket patienten kan inhalere.
Apparatet ifølge opfindelsen er egnet til administrering af mange forskellige medikamenter, såsom salbutamol, bechlomethason-dipropio-nat og dinatrium·chromoglycat.
30 Apparatet ifølge opfindelsen gør brug af medikamentamballeringeteknikken ved tilførsel af medikamenterne i blisterpakninger, dvs. emballager, der har en folie, som kan vare lamineret, af plastmateriale, og som virker som en bareskive, og som har flere beholdere, der kaldes "blister*, som kan brydes eller åbnes, og som har en folie, BNSDOCID: <DK 172541B > 3 DK PR 172541 B1 der er fastgjort pi en første folie til dannelse af et daksel eller låg. Sådanne blisterpakninger er i almindelig brug i forbindelse med tabletter af forskellige typer, men det har vist sig, at de også kan benyttes i forbindelse med medikamenter i findelt fast fonn eller i S flydende form.
Opfindelsen angår også en medikamentpakning til. brug i apparatet ifølge opfindelsen, hvilken medikamentpakning er af den art, der er angivet i krav 9' s indledning og er ejendommelig ved det, der er angivet i krav 9's kendetegnende del.
10 Opfindelsen vil i det følgende blive narmere forklaret under henvisning til tegningen, på hvilken fig. 1 viser en første udførelaesform for et apparat ifølge opfindelsen, adskilt og set i perspektiv, fig. 2 viser, i detaljer, en stempelIndretning i dette apparat, 15 fi9· 3 viser en anden udførelsesform for apparatet ifølge opfindelsen, set i fra siden, fig. 4 viser den i fig. 3 viste udførelsesform, vist adskilt og fig. 5 viser endnu en udførelsesform for apparatet ifølge opfindelsen, set i perspektiv.
20 Z fig. 1 og 2 er vist en udførelsesform for et apparat til administrering af et medikament ifølge opfindelsen og med et lavt cylindrisk hus 1, der er fremstillet af plastmateriale og har et cylindrisk kammer 2. Kammeret er lukket i den ene ende 3, som i det følgende benavnes kammerets bund, og et aftageligt daksel 4 passer 25 stramt over kammeret i den anden ende.
Bt mundstykkeudløb 5 rager udefter fra huset l’a cylindriske vag og står i forbindelse med kammeret 2's indre. En perforeret beskyttel-esplade, der ikke er vist, er monteret i mundstykket for at forhindre eventuelle faste partikler med en uønsket stor størrelse i at 30 blive inhaleret af en patient, som inhalerer gennem mundstykket.
En rand eller skulder € løber rundt langs kammeret 2's indervag for at frembringe en ringformet understøtning, på hvilken en blister-pakning eller emballage kan vare placeret.
aMRnnnirv <-ηκ 4 DK PR 172541 B1
Pakningen 7 kan hensigtsmæssigt vare et folielaminat med flere beholdere, der let brydes, eller blister S, der er placeret i en cirkel. Blisterne S er fyldt med et medikament i findelt form med en partikelstørralea i området 0,5-10 μη. Medikamentet kan have en 5 farmaceutisk acceptabel barer såsom lactose eller stivelse i findelt form. Medikamentet kan i stedet vare i flydende form. Pakningen har cirkular skiveform og passer udskifteligt inden i kammeret, så at den kan udskiftes, når de enkelte medikamentdoser, der er indeholdt i blisterne, er afgivet.
10 Kamneret 2 har en central åben cylindrisk understøtningssøjle 9, der står op fra kammerets bundvag 5. Bn fastspandingspladedel 10 passer aftageligt inden i kammeret 2 og har på sin underside flere lokali-seringatappe, der ikke ar vist, og som indgriber med indersiden af understøtningssøjlen. Pastspandingsdelen 10 kan dreje inden i kamme-15 ret. Onder brug anbringes fastspandingsdelen oven på en pakning 7, der allerede er placeret inden i kamneret på understøtningsskulderen 6. Pakningen 7 er fortrinsvis en cirkular skive af lamineret foliemateriale med blister eller beholdere 8. Fastspandingsdelen 10 har flere åbninger 11, der er placeret på en cirkel og med sådan ind-20 byrdes afstand fra hinanden, at hver af disse åbninger kan optage en af pakningen 7's blister 8. Bn knap 12 strakker sig opad fra fast-spandingsdelen 10, og når låget 4 er monteret på huset 1, rager knappen 12 op gennem en åbning 13 i toppen af låget 4. Denne knap kan drejes af patienten til drejning af fastspandingsdelen 10, og da 25 pakningen 7’s blister 8 er placeret i fastspandingspladen 10's åbninger 11, får drejning af fastspandingsdelen også pakningen til at dreje. På oversiden af fastspandingsdelen 10 findes der flere fremspring eller knaster 14 til indgreb i en udsparing 15, der er vist i fig. 2, på undersiden af dekslet 4 til at sikre, at fastspandings-30 pladen er korrekt placeret på plads. Som det fremgår af figuren, er knappen 12 riflet til frembringelse af åbninger mellem knappen og hullet 13, gennem hvilke der kan passere luft ind i kammeret 2 udefra.
Dakslet 4 har ogaå en åbning 16, i hvilken et stempel 17, der er 35 indeholdt i et stempelhus 18, kan optages. Stemplet har en ringformet skulder 19, og mellem skulderen 19 og bunden af stempelhuset 18 er BNSDOCID· ^DK 17?S41B> 5 DK PR 172541 B1 der lejret: en fjeder 20 til at tvinge stemplet til en åben eller inoperativ stilling. Stemplet kan have sn skarp mg 21 eller et andet organ til at muliggøre, at blisterne kan åbnes. Når stemplet 17 trykkes ned mod fjederen 20's virkning, passerer stemplets nederste 5 skarende del 21 gennem en åbning 22 i stampelhusat og passerer gennem en blist 8, der er placeret ud for steoplet. Dette indgreb åbner blisten og tillader frigivelse af medikament fra samme. Denne virk* ning vil åbne blisten, så at når en patient inhalerer, vil luft passere gennem blisten og føre medikamentet med i luftstrømmen og 10 afgive det gennem mundstykket S via et overførsaIshulrum 23, der er placeret inden i kammeret, og som står i forbindelse med mundstykket S. Ved drejning af knappen 12 kan fastspandingsdelen 10 og pakningen 7 bringes til at dreje, så at hver blist efter tur anbringes på plads under stemplet. De forskellige fremspring eller knaster 14 indgriber 15 efter tur med udsparingen 15 for at sikre, at pakningen er placeret korrekt ud for stemplet.
Det er ikke afgørende, at stemplet har en kniv 21 til åbning af en blist. Der kan eventuelt benyttes en nål eller kanyle til perforering af blisten, ligesom stemplet kan have en spids ende eller endog en 20 stump ende, og et vilkårligt andet passende åbningeorgan kan benyttes.
Udløbdskslet kan have en låsedel 24, der kan indgribe med stemplet, når apparatet ikke benyttes, for at forhindre tilfeldig aktivering af stesplet.
25 Onder brug kan den patient, som behøver en medikamentdosis, holde apparatet med mundstykket i sin mund. Patienten trykker derefter stemplet ned for at åbne en blist og give adgang til medikamentet i samme og inhalerer gennem mundstykket, så at medikamentet bringes med 1 luftstremmen og føres ned i patientens lunger. Mundstykket kan 30 eventuelt vare forsynet med luftindløbsåbninger 25 til forøgelse af luftstrømmen, når patienten inhalerer.
I en ikke vist modifikation kan blisterpakningens underside understøttes på en anden faatspandingaplade i stedet for af understøt-ningsranden eller skulderen 6.
BN5DOCID: <0K 17?541B> 6 DK PR 172541 B1
Pakningen er hensigtsmæssigt indrettet til at tilvejebringe et til-etrækkeligt antal individuelle doser til en patient til brug i løbet af en passende periode, såsom én eller flere dage. Huset kan være modificeret, idet det har et ekstra kammer, der ikke ar synligt, i 5 bunden, idet dette ekstra kammer er lukket med et aftageligt dæksel 26. Dette ekstra kamsier kan benyttes til lagring af ekstra blisterpakninger. Udløbet kan eventuelt være således udformet, at det kan benyttes af en patient til inhalering gennem nasen.
X fig. 3 og 4 er vist en modificeret udførelsesfon· for apparatet, 10 der ikke har nogen faøtøpandingsdel 10. Apparatet i denne modifikation har et hus 30 med et kammer 31. Et mundstykke 32 rager ud fra huset 30's cylindriske veg i en i alt vasentligt radial retning og står i forbindelse sted kammeret 31's indre. En perforeret beskyttel-øesplade 33 er placeret ved indgangen til mundstykket 32. Bn rand IS eller skulder 34 løber langs kammeret 31's indersidevag til tilvejebringelse af en ringformet understøtning til en understøtningsdel 35, der har form af en eirkular plade eller skive. Denne understøtnings-del er indrettet til at optage en blisterpakning 36. Pakningen 36 har flere beholdere 37, der kan brydes, og som er placeret i en cirkel.
20 Disse beholdere har form af blister med en i alt væsentlig konisk form, således som det klart fremgår af fig. 4, og indeholder et medikament som beskrevet under henvisning til fig. l. Understøtnings-delen 35 har flere huller 38, hvis antal er lig med antallet af blister 37 i pakningen 36. Den koniske del af en blist 37 er placeret 25 i hvert af hullerne 38, når apparatet er fyldt og i brug. Bn udvendig drejelig del 39 sied en riflet kant 40 er placeret med sin flede i kontakt med huset 30's bund. Bn tap 41 eller lignende og med radiale fremspring 42 atrakker sig centralt fra underetøtningsdelen 35 gennem et hul 43 i bunden af huset 30 og ind i en åbning 44 sied komplesientar 30 form i en tap 45 på delen 39. Tappen 45 passerer gennem hullet 43, og tappen 41 med fremspringene 42 indgriber i åbningen 44, eå at drejning af delen 39 får understetningsdelen 35 til at dreje tilsvarende.
Et aftageligt dakeal 46 passer oven på huset 30. X dækslet 46 er der udformet en åbning 47, som indgriber med et fremspring 48 af huset 30 35 til korrekt lokalisering af dækslet. Dækslet 46 har en understøtning 49, på hvilken en arm eller aftrækker 50 er monteret drejeligt. Et stempel 51 er monteret på armen eller aftrækkeren 50 og strækker eig BNSDOCIO: <DK 1725416» 7 DK PR 172541 B1 gennem et hul S2 i dakalet. Til lejring mellem aftrakkeren eller armen 50 og dakalet 46' overside findes en fjeder 53, som tvinger armen eller aftrakkeren opefter.
Hullet 52 er placeret således, at hvert hul 38 i underetøtningsdelen 5 35 ligger ud for hullet 52, når understetningedelen 35 drejes.
Hår det ene af hullerne 38 er placeret ud for hullet 52, kan aftrak· keren 50 trykkes ned, så at stemplet 51, der kan have form af en nål, tranger gennem den blist 37, som er placeret i dette hul dvs. per· forerer tappen og bunden af blisten, hvorved pulveret kan afgives fra 10 blisten. Bn del af pulveret vil falde ned i en skuffelignende del 54 i kammeret 31. Hår patienten inhalerer, passerer der luft gennem den perforerede blist, så at pulveret føres med i luftstrømmen og sammen med pulveret i delen 54 bliver trukket gennem beskyttelsespladen 33 og mundstykket 32. Hår apparatet ikke er i brug kan mundstykket 32 15 indesluttes i et mundstykkedaksel eller en skede 55, der har en kanallignende forlangelse 56, som indgriber med understøtningen 49 for at forhindre, at atemplet 51 trykkes ned og føres gennem hullet 37.
Hår indretningen er i brug, og patienten inhalerer gennem udløbet 32, 20 er det naturligvis afgørende, at der kan passere luft ind i kammeret 31'e indre. Vilkårlige passende luftindløb kan vare udformet. Det er imidlertid hensigtsmassigt, at der kan passere luft gennem hullet 52, idet stemplet eller nålen 51 har en siindre diameter end diameteren af hullet 52, så at dette tjener som et luftindløb.
25 Big. 5 viser et modificeret apparat, der passende kan benyttes til administrering af to forskellige swdikamenter til en patient på forskellige tidspunkter. Behandling af visse patienter kraver, at de inhalerer to forskellige typer medikamenter, i det i fig. 5 viste ap* parat har et falles hus 57 to kamre, der svarer til kammeret 2 i den 30 i fig. 1 og 2 viste udførelaesform eller til kammeret 31 i den i fig-3 og 4 viste udførelaesform. Disse to kamre er lukket med aftagelige dakaler 58, og blieterpakninger, der er indeholdt i kamrene, kan drejes på de ovenfor beskrevne måder ved drejning af riflede hjul, knapper eller andre organer 59. Pra det fallee hua 57 atrakker der 5NSD0CID; <DK 17?<U13>
Claims (10)
1. Apparat til administrering af medikamenter til patienter, hvilket apparat omfatter et hue (1, 30) med et cylindrisk kammer (2, 31), et luftindleb til kammeret, en understøtning, der er placeret Inden i 10 kammeret, og som er indrettet til at understøtte en bereekive (7, 36) med en eller flere beholdere (8, 37), hvori et medikament er indeholdt, hvilke beholdere er placeret i en cirkel, et stempel (17, si), der kan drives til at indgribe med en beholder, der er placeret ud for stamp 1st, til Åbning af beholderen, organer til drejning af 15 bereskiven på understøtningen til anbringelse af beholderen eller hver af dieae efter tur ud for stemplet, samt et udløb (S, 32), der står i forbindelse med kammerets indre, og gennem hvilket en patient kan inhalere, hvorved der fra en beholder frigives medikament, som føree med i den luftstrøm, der frembringes af patienten, sA at me-20 dikamentet ledes gennem udløbet (5, 32), kendetegnet ved, at bereskivens (7, 36) beholdere (8, 37) er udformet i ét med børeskiven, og at understøtningen er indrettet til at holde børeskiven (7, 36) stationer borteet fra drejebevegel-een, idet medikamentet frigøres gennem patientens inhalering fra en 25 Åbnet beholder, mens denne er stationer, og hvor understøtningen omfatter en drejelig plade (10, 35) med flere huller (11, 38), der strekker aig gennem pladen, og som er placeret i en cirkel, og hver er indrettet til at optage en beholder (8, 37) med medikament.
2. Apparat ifelge krav l, 30 kendetegnet ved, at den omfatter en drejelig del (12, 39), der er placeret uden for kammeret (2, 31) og er forblindet med den drejelige plade, så at drejning af denne del fAr den drejelige plade (10, 35) til at dreje. BNSDOCID: <DK 172541B > DK PR 172541 B1 9
3. Apparat ifølge krav i, kendetegnet ved, at udløbet (S, 32) fører ud fra kammeret (5, 32) i en i alt vasentligt radial retning, og at en perforeret beskytteleeeplade (33) er placeret på en sådan måde, at luft og S medikament, som inhaleres gennem udløbet (S, 32), først skal passere gennem denne plade.
4. Apparat ifølge et hvilket som helst af de foregående krav, kendetegnet ved, at understøtningen omfatter en rand (C) inden i kammeret (2) sammen med en drejelig plade (10), hvor pladen 10 (10) er monteret inden i kammeret på understøtningen, men er aftage lig for at tillade, at en bareskive (7) kan anbringes på understøtningen (6) og derefter spandes fast mellem pladen (10) og understøtningen (6) .
5. Apparat ifølge et hvilket som helst af de foregående krav, IS kendetegnet ved, at kammeret har et daksel (4, 46), der er aftageligt for at tillade, at en bareskive (7, 36) kan indsattes i kammeret og anbringes på understøtningen, idet stemplet (17, Si) bares af dakslet.
6. Apparat ifølge et hvilket som helst af de foregående krav, 20 kendetegnet ved, at udløbet (32) er indesluttet i et aftageligt udløbsdakael (55), der har organer (S6) til at forhindre aktivering af stemplet (51), når udlebsdakslet (SS) er anbragt på udløbet (52).
7. Apparat ifølge et hvilket som helst af de foregående krav, 25 kendetegnet ved, at det er ét af to apparater placeret i et falles hus (57). Θ. Apparat ifølge et hvilket som helst af de foregående krav, kendetegnet ved, at bareskiven (7, 36) er en integral blisterpakning.
9. Medikamentpakning til brug i et apparat ifølge et hvilket som helst af de foregående krav, hvilken medikamentpakning omfatter en cirkuler bareskive (7, 36) med flere beholdere (8,37), tiM'iDOCID: <DK )7?541B > 10 DK PR 172541 B1 der er udformet i ét med bareskiven 09 er placeret i en cirkel, 09 •om hver indeholder en dosis af et medikament i findelt form, kendetegnet ved, at beholderne er indrettet til at kunne gennemhulle· på begge sider af bareskiven sådan, at luft kan strømme S gennem beholderen og optage medikamentet i luftstrømmen.
10. Medikamentpakning ifølge krav 9, kendetegnet ved, at beholderne har en i alt vasentligt konisk form.
11. Medikamentpakning ifølge krav 9 eller 10, 10 kendetegnet ved, at bareskiven er af lamineret foliemateriale . 8NSDOCIO: <DK 1725418 >
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK199800451A DK173079B1 (da) | 1982-10-08 | 1998-03-31 | Medikamentpakning |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8228887 | 1982-10-08 | ||
| GB8228887 | 1982-10-08 | ||
| GB838314307A GB8314307D0 (en) | 1983-05-24 | 1983-05-24 | Medical administration devices |
| GB8314307 | 1983-05-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK464383D0 DK464383D0 (da) | 1983-10-07 |
| DK464383A DK464383A (da) | 1984-04-09 |
| DK172541B1 true DK172541B1 (da) | 1998-12-07 |
Family
ID=26284076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198304643A DK172541B1 (da) | 1982-10-08 | 1983-10-07 | Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4627432A (da) |
| JP (2) | JPH05200100A (da) |
| KR (1) | KR910002248B1 (da) |
| AT (1) | AT396333B (da) |
| AU (2) | AU570013B2 (da) |
| BR (1) | BR8305562A (da) |
| CA (1) | CA1224992A (da) |
| CH (1) | CH662277A5 (da) |
| CY (2) | CY1477A (da) |
| DE (1) | DE3336486A1 (da) |
| DK (1) | DK172541B1 (da) |
| ES (1) | ES286422Y (da) |
| FI (1) | FI79651C (da) |
| FR (2) | FR2550452B1 (da) |
| GB (1) | GB2129691B (da) |
| GR (1) | GR79615B (da) |
| HK (1) | HK67789A (da) |
| IE (1) | IE56059B1 (da) |
| IL (1) | IL69932A (da) |
| IN (1) | IN160851B (da) |
| IT (1) | IT1203660B (da) |
| KE (1) | KE3860A (da) |
| LU (1) | LU85034A1 (da) |
| NL (1) | NL192564C (da) |
| NO (1) | NO160330C (da) |
| NZ (1) | NZ205892A (da) |
| PT (1) | PT77471B (da) |
| SE (2) | SE458824B (da) |
| SG (1) | SG6889G (da) |
| ZW (1) | ZW21483A1 (da) |
Families Citing this family (399)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3348370C2 (de) * | 1982-10-08 | 2001-10-11 | Glaxo Group Ltd | Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms |
| SE448277B (sv) * | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| EP0211595B1 (en) * | 1985-07-30 | 1991-11-13 | Glaxo Group Limited | Devices for administering medicaments to patients |
| SE8605130L (sv) * | 1986-07-24 | 1988-01-25 | Marcus Diamant | Redskap for utklemning av tabletter fran tablettkartor och liknande |
| US4817800A (en) * | 1987-05-20 | 1989-04-04 | Surgikos, Inc. | Fluid injection system cassette and fluid packaging methods |
| FR2626500B1 (fr) * | 1988-01-28 | 1990-04-27 | Valois Sa | Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet |
| CH678151A5 (en) * | 1988-07-13 | 1991-08-15 | Heinz Hermann Weick | Self-medication nasal dispenser |
| US5239991A (en) * | 1989-06-21 | 1993-08-31 | Fisons Plc | Disposable powder medicament inhalation device with peel-off cover |
| GB8914223D0 (en) * | 1989-06-21 | 1989-08-09 | Fisons Plc | Medicament container |
| IT1230313B (it) * | 1989-07-07 | 1991-10-18 | Somova Spa | Inalatore per medicamenti in capsule. |
| DE3927170A1 (de) * | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
| US5009561A (en) * | 1989-08-18 | 1991-04-23 | Pharmacia Diagnostics Inc. | Reagent tablet dispenser |
| HU213221B (en) | 1990-03-02 | 1997-03-28 | Glaxo Group Ltd | Inhalation device and medicine packet for device |
| YU48707B (sh) * | 1990-03-02 | 1999-07-28 | Glaxo Group Limited | Aparat za inhaliranje - inhalator |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| GB9012870D0 (en) * | 1990-06-08 | 1990-08-01 | Glaxo Group Ltd | Device |
| DE4021263C2 (de) * | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| IT1243344B (it) * | 1990-07-16 | 1994-06-10 | Promo Pack Sa | Inalatore plurimonodose per medicamenti in polvere |
| GB9021433D0 (en) * | 1990-10-02 | 1990-11-14 | Atomic Energy Authority Uk | Power inhaler |
| FR2667509B1 (fr) * | 1990-10-04 | 1995-08-25 | Valois | Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes. |
| US5042472A (en) * | 1990-10-15 | 1991-08-27 | Merck & Co., Inc. | Powder inhaler device |
| NL9002706A (nl) * | 1990-12-10 | 1992-07-01 | Pharmachemie Bv | Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen. |
| GB2253200A (en) * | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
| US5243970A (en) * | 1991-04-15 | 1993-09-14 | Schering Corporation | Dosing device for administering metered amounts of powdered medicaments to patients |
| US5327883A (en) * | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
| US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
| US5337740A (en) * | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
| US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
| USD350602S (en) | 1991-11-01 | 1994-09-13 | Rhone-Poulenc Rorer Limited | Combined dry powder inhaler and cap |
| DE4142238A1 (de) * | 1991-12-20 | 1993-06-24 | Boehringer Ingelheim Kg | Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen |
| GB2264237A (en) * | 1992-02-05 | 1993-08-25 | Robert Edward Newell | An inhaler |
| GB9203761D0 (en) * | 1992-02-21 | 1992-04-08 | Innovata Biomed Ltd | Inhaler |
| US5301664A (en) * | 1992-03-06 | 1994-04-12 | Sievers Robert E | Methods and apparatus for drug delivery using supercritical solutions |
| US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| DE69322789T2 (de) * | 1992-10-19 | 1999-07-01 | Dura Pharmaceuticals, Inc., San Diego, Calif. | Trockenpulverinhalator |
| SE9203743D0 (sv) * | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
| US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
| US5368187A (en) * | 1993-01-19 | 1994-11-29 | Poncetta; Stanley | Method and apparatus for dispensing materials from blister packages |
| US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
| US5558085A (en) * | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5743250A (en) | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
| US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| US6024090A (en) * | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
| US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
| US5819726A (en) * | 1993-01-29 | 1998-10-13 | Aradigm Corporation | Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease |
| US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
| US5724957A (en) * | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
| US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
| US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
| US6098620A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
| CA2157584C (en) * | 1993-03-03 | 1999-05-04 | Paul Mulhauser | Dry powder medicament inhalator |
| TW360548B (en) | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
| US5372128A (en) * | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
| US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| US5709202A (en) * | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
| US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
| US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
| US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
| USD358880S (en) | 1993-12-02 | 1995-05-30 | Tenax Corporation | Dry powder inhalator |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| ES2218543T3 (es) * | 1994-03-07 | 2004-11-16 | Nektar Therapeutics | Procedimiento y preparacion para la administracion de insulina por via pulmonar. |
| US5664557A (en) * | 1994-03-10 | 1997-09-09 | Respiratory Delivery Systems, Inc. | Releasably engageable coupling for an inhaler |
| US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
| GB9409851D0 (en) * | 1994-05-17 | 1994-07-06 | Cambridge Consultants | Improvements in and relating to containers of particulate material |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| CN1318104C (zh) * | 1994-09-21 | 2007-05-30 | 耐科塔医药公司 | 送料管组件 |
| US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
| FR2725626A1 (fr) * | 1994-10-18 | 1996-04-19 | Sofab | Dispositif pour l'inhalation de produits en poudre |
| DE19500764C2 (de) * | 1995-01-13 | 2001-09-27 | Sofotec Gmbh & Co Kg | Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form |
| DE19502725B4 (de) * | 1995-01-28 | 2004-03-04 | Ing. Erich Pfeiffer Gmbh & Co Kg | Austragvorrichtung für Medien |
| US5676643A (en) * | 1995-02-13 | 1997-10-14 | The Procter & Gamble Company | Dispenser for friably releasing dry particulate medicaments |
| US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5921237A (en) * | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
| US5669973A (en) * | 1995-06-06 | 1997-09-23 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing and retaining materials upon a substrate |
| US5714007A (en) * | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
| US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
| US20040237961A1 (en) * | 1995-06-08 | 2004-12-02 | Snow John Medlin | Inhalation actuated device for use with metered dose inhalers (MDIs) |
| DE19523516C1 (de) * | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
| US5642727A (en) * | 1995-07-25 | 1997-07-01 | David Sarnoff Research Center, Inc. | Inhaler apparatus using a tribo-electric charging technique |
| US6209538B1 (en) * | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
| US5692496A (en) * | 1995-08-02 | 1997-12-02 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
| US5823183A (en) * | 1995-08-02 | 1998-10-20 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
| US5988163A (en) * | 1995-08-02 | 1999-11-23 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament |
| NL1001031C1 (nl) * | 1995-08-23 | 1997-02-25 | Npk Ind Design B V | Inrichting voor het afgeven van pillen uit een blisterverpakking. |
| ES2216418T3 (es) | 1995-12-07 | 2004-10-16 | Jago Research Ag | Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico. |
| US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| US5669378A (en) * | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
| US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
| USD395499S (en) | 1996-04-08 | 1998-06-23 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5743251A (en) * | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
| US5871010A (en) * | 1996-06-10 | 1999-02-16 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
| US5857456A (en) * | 1996-06-10 | 1999-01-12 | Sarnoff Corporation | Inhaler apparatus with an electronic means for enhanced release of dry powders |
| US20030203036A1 (en) | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
| AU5806998A (en) | 1996-12-31 | 1998-07-31 | Inhale Therapeutic Systems | Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
| DE19704849B4 (de) * | 1997-02-08 | 2011-02-17 | Ing. Erich Pfeiffer Gmbh | Austragvorrichtung für Medien |
| US6006747A (en) * | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5909822A (en) * | 1997-05-03 | 1999-06-08 | George; Donald C. | Pill dispenser employing a sealed pill carrier |
| US5915560A (en) * | 1997-05-03 | 1999-06-29 | George; Donald C. | Compartmentalized pill dispenser |
| USD412978S (en) | 1997-12-02 | 1999-08-17 | Dura Pharmaceuticals, Inc. | Inhaler |
| CN1301185A (zh) | 1997-12-02 | 2001-06-27 | 杜兰药品公司 | 干粉吸入器 |
| US6116238A (en) * | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| JP4423457B2 (ja) | 1998-01-16 | 2010-03-03 | トルーデル メディカル インターナショナル | ディスペンサおよび投与装置用表示装置 |
| AU750539B2 (en) | 1998-03-16 | 2002-07-18 | Novartis Ag | Aerosolized active agent delivery |
| US6729330B2 (en) | 1998-05-05 | 2004-05-04 | Trudell Medical International | Indicating device for aerosol container |
| US6336453B1 (en) | 1999-04-30 | 2002-01-08 | Trudell Medical International | Indicating device for aerosol container |
| US6082358A (en) | 1998-05-05 | 2000-07-04 | 1263152 Ontario Inc. | Indicating device for aerosol container |
| US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
| US6149774A (en) | 1998-06-10 | 2000-11-21 | Delsys Pharmaceutical Corporation | AC waveforms biasing for bead manipulating chucks |
| DE19831525A1 (de) * | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
| UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
| US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
| US6923979B2 (en) * | 1999-04-27 | 2005-08-02 | Microdose Technologies, Inc. | Method for depositing particles onto a substrate using an alternating electric field |
| DE29908593U1 (de) | 1999-05-14 | 1999-07-22 | Jago Research AG, Hergiswil | Mundstück für einen Inhalator zur Abgabe eines Medikaments |
| ATE294608T1 (de) | 1999-06-05 | 2005-05-15 | Innovata Biomed Ltd | Verabreichungsystem für medikamente |
| US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
| US6730066B1 (en) | 1999-08-03 | 2004-05-04 | Pharmacia Ab | Liquid delivery container |
| GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| US6810872B1 (en) | 1999-12-10 | 2004-11-02 | Unisia Jecs Corporation | Inhalant medicator |
| US20010029947A1 (en) | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders |
| US7069929B2 (en) * | 2000-02-01 | 2006-07-04 | Quadrant Technologies Limited | Dry powder inhaler |
| US6427688B1 (en) * | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
| BR0108730A (pt) | 2000-02-28 | 2002-11-05 | Vectura Ltd | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados |
| US6883516B2 (en) | 2000-04-27 | 2005-04-26 | Chrysalis Technologies Incorporated | Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution |
| MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
| US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
| GB0015034D0 (en) * | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Inhalation device |
| TWI224515B (en) * | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
| US7575761B2 (en) | 2000-06-30 | 2009-08-18 | Novartis Pharma Ag | Spray drying process control of drying kinetics |
| EP2067784A3 (en) | 2000-08-05 | 2012-08-22 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| EP1315533A4 (en) * | 2000-08-15 | 2007-06-27 | Univ Kentucky Res Found | PROGRAMMABLE MULTI-DOSE DEVICE FOR INTRANASAL MEDICINE ADMINISTRATION |
| US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
| US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
| US7077130B2 (en) | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
| US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
| US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
| US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
| GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| AU2002238801A1 (en) | 2001-03-20 | 2002-10-03 | Trudell Medical International | Nebulizer apparatus and method |
| WO2002076933A1 (en) | 2001-03-22 | 2002-10-03 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
| WO2002088167A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| US6745760B2 (en) | 2001-05-15 | 2004-06-08 | Trudell Medical International | Medicament applicator |
| US8061006B2 (en) | 2001-07-26 | 2011-11-22 | Powderject Research Limited | Particle cassette, method and kit therefor |
| US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| ATE417606T1 (de) | 2001-09-14 | 2009-01-15 | Glaxo Group Ltd | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege |
| US8337816B2 (en) | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
| JP4261351B2 (ja) | 2001-09-19 | 2009-04-30 | アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド | 吸入器 |
| US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
| US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
| US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
| US6804458B2 (en) * | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
| US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
| US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
| US7458373B2 (en) | 2002-01-15 | 2008-12-02 | Philip Morris Usa Inc. | Aerosol generator for drug formulation |
| GB0201677D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
| GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| AU2003216401A1 (en) * | 2002-03-01 | 2003-09-16 | Glaxo Group Limited | Rotary blending apparatus and system |
| CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
| US7004164B2 (en) | 2002-03-21 | 2006-02-28 | Trudell Medical International | Indicating device for aerosol container |
| AU2003225973A1 (en) * | 2002-03-26 | 2003-11-11 | Glaxo Group Limited | A method for forming a laminate assembly and products formed thereby |
| US20030235538A1 (en) | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
| UA80123C2 (en) * | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
| DE10217929A1 (de) * | 2002-04-22 | 2003-11-06 | Sixp Ag | Vorrichtung zur Ausgabe von Tabletten |
| US7429127B2 (en) * | 2002-04-25 | 2008-09-30 | Glaxo Group Limited | Magnetoacoustic sensor system and associated method for sensing environmental conditions |
| ATE381535T1 (de) * | 2002-04-25 | 2008-01-15 | Glaxo Group Ltd | Phenethanolaminderivate |
| GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
| GB2388040B (en) * | 2002-05-02 | 2005-12-14 | Robert Jeremy West | Nicotine inhalation device |
| US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
| AU2003222642A1 (en) * | 2002-05-10 | 2003-11-11 | Chrysalis Technologies Incorporated | Aerosol generator for drug formulation and methods of generating aerosol |
| WO2003107397A2 (en) * | 2002-05-15 | 2003-12-24 | Glaxo Group Limited | Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging |
| US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
| US7185651B2 (en) | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
| AU2003254590A1 (en) * | 2002-07-25 | 2004-02-16 | Glaxo Group Limited | Medicament dispenser |
| US20050268908A1 (en) * | 2002-07-25 | 2005-12-08 | Bonney Stanley G | Medicament dispenser |
| GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| CA2497871C (en) | 2002-09-06 | 2012-04-17 | Chrysalis Technologies Incorporated | Aerosol generating devices and methods for generating aerosols having controlled particle sizes |
| US20070139442A1 (en) * | 2002-09-13 | 2007-06-21 | Robinson Karl E | Coated blending system |
| US6772757B2 (en) | 2002-10-25 | 2004-08-10 | Chrysalis Technologies Incorporated | Concentric controlled temperature profile fluid vaporizing device |
| US7442839B2 (en) | 2002-10-28 | 2008-10-28 | Glaxo Group Limited | Phenethanolamine derivative for the treatment of respiratory diseases |
| AU2003293361A1 (en) * | 2002-12-18 | 2004-07-29 | Glaxo Group Limited | Drug delivery system with vented mouthpiece |
| US20040173211A1 (en) * | 2003-01-14 | 2004-09-09 | Boehringer Ingelheim International Gmbh | Powder inhaler |
| GB2412363C (en) * | 2003-02-05 | 2006-08-03 | Martin John Tedham | Dispenser |
| GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
| DE10317461A1 (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
| EP1488819A1 (en) * | 2003-06-16 | 2004-12-22 | Rijksuniversiteit te Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
| GB0315509D0 (en) * | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
| AR045914A1 (es) | 2003-07-17 | 2005-11-16 | Glaxo Group Ltd | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
| US7367334B2 (en) | 2003-08-27 | 2008-05-06 | Philip Morris Usa Inc. | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
| SI1677795T1 (sl) | 2003-10-14 | 2011-04-29 | Glaxo Group Ltd | Antagonisti muskarinskega acetilholinskega receptorja |
| EP1677796A4 (en) | 2003-10-17 | 2006-12-27 | Glaxo Group Ltd | MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| WO2005044173A1 (en) * | 2003-10-27 | 2005-05-19 | Oriel Therapeutics, Inc. | Blister packages and associated methods of fabricating dry powder drug containment systems |
| US7621273B2 (en) | 2003-10-28 | 2009-11-24 | Trudell Medical International | Indicating device with warning dosage indicator |
| PE20050489A1 (es) | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| EP1691782A1 (en) * | 2003-12-03 | 2006-08-23 | Microdrug AG | Medical product containing tiotropium |
| SE0303270L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Metod för administration av tiotropium |
| US7100530B2 (en) | 2003-12-15 | 2006-09-05 | Trudell Medical International, Inc. | Dose indicating device |
| GB0329182D0 (en) | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Chemical compounds |
| US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
| US7384946B2 (en) | 2004-03-17 | 2008-06-10 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| WO2005095328A1 (en) | 2004-04-02 | 2005-10-13 | Glaxo Group Limited | Chemical process and new crystalline form |
| WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
| EP1747219A4 (en) | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
| GB0418738D0 (en) * | 2004-08-23 | 2004-09-22 | 3M Innovative Properties Co | Medicinal aerosol formulation receptacle and production thereof |
| US7543582B2 (en) | 2004-09-20 | 2009-06-09 | Trudell Medical International | Dose indicating device with display elements attached to container |
| EP1827541B1 (de) * | 2004-10-21 | 2013-05-29 | Boehringer Ingelheim International GmbH | Blister für inhalatoren |
| US8165460B2 (en) * | 2004-10-26 | 2012-04-24 | The University Of North Carolina At Chapel Hill | Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods for using |
| JP2006130143A (ja) * | 2004-11-08 | 2006-05-25 | Hitachi Ltd | 吸入式投薬器及び薬剤カートリッジ |
| US20080042823A1 (en) * | 2004-11-12 | 2008-02-21 | Heasley Matthew G | Sensor System with Acoustic Transducer |
| US7743945B2 (en) | 2005-01-20 | 2010-06-29 | Trudell Medical International | Dispensing device |
| WO2006084033A1 (en) | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| RU2007133547A (ru) | 2005-02-10 | 2009-03-20 | Глаксо Груп Лимитед (GB) | Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции |
| PE20061351A1 (es) | 2005-03-25 | 2007-01-14 | Glaxo Group Ltd | COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38 |
| TW200724142A (en) | 2005-03-25 | 2007-07-01 | Glaxo Group Ltd | Novel compounds |
| GB0507711D0 (en) | 2005-04-15 | 2005-05-25 | Vectura Group Plc | Improved blister piercing |
| US9585932B2 (en) | 2005-04-29 | 2017-03-07 | Peter C. Dowling | Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders |
| US8653028B2 (en) * | 2005-04-29 | 2014-02-18 | Rui Rong Yuan | Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| US9345745B2 (en) | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
| EP1879579A1 (en) * | 2005-05-04 | 2008-01-23 | Boehringer Ingelheim International GmbH | Inhalation device containing plural doses of a pharmaceutical composition |
| DE102005035705A1 (de) | 2005-07-27 | 2007-02-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittelblister |
| WO2007022351A2 (en) | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| CA2620123C (en) * | 2005-08-24 | 2011-11-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis |
| US20090192227A1 (en) * | 2005-08-24 | 2009-07-30 | Rabindra Tirouvanziam | N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease |
| TWI274641B (en) * | 2005-08-30 | 2007-03-01 | Rexon Ind Corp Ltd | Cutting machine |
| US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
| US8227408B2 (en) * | 2005-09-07 | 2012-07-24 | Neurotez, Inc. | Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |
| US20070178141A1 (en) * | 2005-09-07 | 2007-08-02 | Bebaas, Inc. | Vitamin B12 compositions |
| US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
| EP1795221A1 (en) * | 2005-12-02 | 2007-06-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US8037880B2 (en) * | 2006-04-07 | 2011-10-18 | The University Of Western Ontario | Dry powder inhaler |
| EP1844808A1 (de) * | 2006-04-13 | 2007-10-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medikamenten-Ausgabevorrichtung |
| EP1844809A1 (de) * | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator |
| DE102006023662A1 (de) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalator |
| DE102006043637A1 (de) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zerstäuber |
| US9457161B2 (en) | 2006-05-18 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Inhaler |
| US8141550B2 (en) | 2006-08-01 | 2012-03-27 | Trudell Medical International | Dispensing device |
| US8161966B2 (en) * | 2006-08-21 | 2012-04-24 | Trudell Medical International | Respiratory muscle endurance training device and method for the use thereof |
| DE102006045788A1 (de) * | 2006-09-26 | 2008-03-27 | Alfred Von Schuckmann | Spender für pulverförmige Massen |
| CA2667225C (en) | 2006-10-25 | 2015-06-09 | Novartis Ag | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices |
| GB0621957D0 (en) * | 2006-11-03 | 2006-12-13 | Vectura Group Plc | Inhaler devices and bespoke pharmaceutical compositions |
| EP1925295A1 (de) | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
| BRPI0806474A2 (pt) | 2007-01-09 | 2011-09-27 | Mystic Pharmaceuticals Inc | dispositivos de cartucho intranasal |
| DK2155228T3 (da) | 2007-01-10 | 2014-07-07 | Purdue Research Foundation | Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
| EP1992376A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992374A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992378A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992373A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992380A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992379A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992372A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP1992377A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| AT505246B8 (de) * | 2007-06-01 | 2009-06-15 | Croma Pharma Gmbh | Container für eine mehrzahl von einzeldosen sowie applikator für derartige container |
| JP5328776B2 (ja) * | 2007-06-01 | 2013-10-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 小出し器具 |
| JP5703466B2 (ja) * | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | キナーゼ阻害薬およびその使用 |
| EP2042208A1 (en) * | 2007-09-25 | 2009-04-01 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2082763A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
| US20110203586A1 (en) * | 2008-02-20 | 2011-08-25 | Boehringer Ingelheim International Gmbh | Powder Inhalers |
| US8118713B2 (en) | 2008-02-21 | 2012-02-21 | Trudell Medical International | Respiratory muscle endurance training device and method for the use thereof |
| US20090235929A1 (en) * | 2008-03-19 | 2009-09-24 | Marc Egen | Powder inhalers |
| US8082873B2 (en) | 2008-05-05 | 2011-12-27 | Trudell Medical International | Drive mechanism for an indicating device |
| JP5622720B2 (ja) * | 2008-05-21 | 2014-11-12 | ニューロテスインコーポレイテッド | 神経原繊維変化に関連する進行性認知障害の治療方法 |
| US8181591B1 (en) | 2008-05-23 | 2012-05-22 | Trudell Medical International | Domed actuator for indicating device |
| GB2463451A (en) | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
| US8381721B2 (en) | 2008-09-26 | 2013-02-26 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members and related devices and methods |
| EP2346554B1 (en) * | 2008-09-26 | 2015-09-16 | Oriel Therapeutics, Inc. | Inhaler mechanisms with radially biased piercers and related methods |
| CA2732842C (en) | 2008-09-26 | 2018-01-09 | Oriel Therapeutics, Inc. | Inhalers with airway disks having discrete airway channels and related disks and methods |
| US9050427B2 (en) * | 2008-09-30 | 2015-06-09 | Oriel Therapeutics, Inc. | Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods |
| WO2010039202A2 (en) * | 2008-10-01 | 2010-04-08 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
| KR20110083651A (ko) * | 2008-10-08 | 2011-07-20 | 아스트라제네카 아베 | 가청 표시기 수단을 갖는 흡입기 |
| KR20170001756A (ko) * | 2008-10-20 | 2017-01-04 | 모레 매트릭스 인코포레이티드 | 유착 치료 또는 예방용 폴리펩티드 |
| US8596265B2 (en) | 2008-10-22 | 2013-12-03 | Trudell Medical International | Modular aerosol delivery system |
| CA2742600A1 (en) * | 2008-11-04 | 2010-05-14 | Nikolaos Tezapsidis | Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| CA2744913A1 (en) * | 2008-12-03 | 2010-06-10 | Boehringer Ingelheim International Gmbh | Inhaler |
| AU2009324661A1 (en) * | 2008-12-10 | 2011-07-07 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| GB0901520D0 (en) * | 2009-01-30 | 2009-03-11 | Vectura Delivery Devices Ltd | Inhaler |
| JP5809985B2 (ja) | 2009-02-26 | 2015-11-11 | グラクソ グループ リミテッドGlaxo Group Limited | 4−{(1r)−2−[(6−{2−[(2,6−ジクロロベンジル)オキシ]エトキシ}ヘキシル)アミノ]−1−ヒドロキシエチル}−2−(ヒドロキシメチル)フェノールを含む医薬製剤 |
| US9119924B2 (en) | 2009-03-17 | 2015-09-01 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing a formulation |
| US8763606B2 (en) * | 2009-05-21 | 2014-07-01 | Microdose Therapeutx, Inc. | Rotary cassette system for dry powder inhaler |
| US8985101B2 (en) | 2009-05-21 | 2015-03-24 | Microdose Therapeutx, Inc. | Method and device for clamping a blister within a dry powder inhaler |
| EP2443134A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
| SG10201500620PA (en) | 2009-07-24 | 2015-03-30 | Amazentis Sa | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| WO2011017132A2 (en) * | 2009-07-27 | 2011-02-10 | Purdue Research, Foundation | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| ES2702753T3 (es) | 2010-01-05 | 2019-03-05 | Microdose Therapeutx Inc | Dispositivo de inhalación |
| US8135497B2 (en) | 2010-01-13 | 2012-03-13 | Joslyn Matthew I | Portable, personal medication dispensing apparatus and method |
| PL2547307T3 (pl) | 2010-03-18 | 2015-03-31 | Medcomb Holding Aps | System do otwierania medycznego opakowania blistrowego |
| USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
| USD635246S1 (en) | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
| AU2011298315B2 (en) | 2010-08-31 | 2014-08-28 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
| EP3461474B1 (en) | 2010-08-31 | 2020-11-11 | GlaxoSmithKline Intellectual Property Development Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
| USD666492S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
| USD666096S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
| USD666097S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
| USD666493S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
| USD666099S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
| USD666098S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
| WO2012064286A1 (en) | 2010-11-11 | 2012-05-18 | Agency For Science, Technology And Research | Targeting metabolic enzymes in human cancer |
| SG194135A1 (en) | 2011-04-12 | 2013-11-29 | Matrix Inc Moerae | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| MX346244B (es) | 2011-05-19 | 2017-03-13 | Savara Inc | Composiciones de vancomicina en polvo seco y metodos asociados. |
| US8585659B2 (en) * | 2011-05-31 | 2013-11-19 | Mystic Pharmaceuticals, Inc. | Piercing device for drug delivery systems |
| GB201116641D0 (en) | 2011-09-27 | 2011-11-09 | Glaxo Group Ltd | Novel compounds |
| EP2589381B1 (en) | 2011-11-04 | 2016-08-31 | Rabindra Tirouvanziam | Compositions for improving or preserving lung function in a patient with a pulmonary disorder |
| WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
| CN104379559B (zh) | 2012-04-27 | 2016-11-09 | 葛兰素集团有限公司 | 化合物 |
| GB201207406D0 (en) | 2012-04-27 | 2012-06-13 | Glaxo Group Ltd | Novel compounds |
| PL2892524T3 (pl) | 2012-09-04 | 2021-10-25 | Eleison Pharmaceuticals, Llc | Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami |
| SG11201503697TA (en) | 2012-11-28 | 2015-06-29 | Intercept Pharmaceuticals Inc | Treatment of pulmonary disease |
| GB201301192D0 (en) | 2013-01-23 | 2013-03-06 | Vectura Delivery Devices Ltd | A blister piercing element for a dry powder inhaler |
| JP2015037466A (ja) * | 2013-04-08 | 2015-02-26 | ニップファーマ株式会社 | 薬剤吸入デバイス |
| KR102300576B1 (ko) | 2013-09-10 | 2021-09-08 | 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 | 절단된 선종성 결장 폴립증 (apc) 단백질을 타겟화하는 치료제 |
| DE14853999T1 (de) | 2013-10-15 | 2017-02-16 | Jesse, Ryan Hancock | Verwirbelungsdüse mit steuerbarer geschwindigkeit |
| US10336788B2 (en) | 2014-04-17 | 2019-07-02 | Moerae Matrix, Inc. | Inhibition of cardiac fibrosis in myocardial infarction |
| CN106456445B (zh) * | 2014-04-24 | 2019-11-15 | 奎斯塔公司 | 多尺寸药丸分割器以及方法 |
| WO2015173701A2 (en) | 2014-05-12 | 2015-11-19 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions for treating infectious diseases |
| US10082496B2 (en) | 2014-09-10 | 2018-09-25 | Board Of Regents Of The University Of Texas System | Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis |
| AU2015338717B2 (en) | 2014-10-31 | 2018-12-20 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
| KR20170083063A (ko) | 2014-11-17 | 2017-07-17 | 모레 매트릭스 인코포레이티드 | 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법 |
| EP3229831B1 (en) | 2014-12-10 | 2020-03-11 | Hyperstem SA | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors |
| USD754919S1 (en) * | 2014-12-19 | 2016-04-26 | Fontem Holdings 4 B.V. | Mouthpiece |
| US10087225B2 (en) | 2015-01-08 | 2018-10-02 | Moerae Matrix, Inc. | Formulation of MK2 inhibitor peptides |
| JP2018504210A (ja) | 2015-01-21 | 2018-02-15 | マイラン・インコーポレイテッドMylan Inc. | 医薬品包装および投与計画システム |
| EP3268032A1 (en) | 2015-03-11 | 2018-01-17 | GlaxoSmithKline Intellectual Property Development Limited | Tslp binding proteins |
| RU2017135072A (ru) | 2015-03-12 | 2019-04-10 | Мори Матрикс, Инк. | Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого |
| US20180154103A1 (en) * | 2015-05-22 | 2018-06-07 | Compressed Perforated Puck Technologies Inc. | Vaporizer apparatus for compressed tablet and loose fill plant source materials |
| CA2987071A1 (en) | 2015-06-10 | 2016-12-15 | Hackensack University Medical Center | Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases |
| KR20180017038A (ko) | 2015-06-15 | 2018-02-20 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
| PH12017502255B1 (en) | 2015-06-15 | 2022-07-22 | Astex Therapeutics Ltd | Nrf2 regulators |
| KR20180018684A (ko) | 2015-06-15 | 2018-02-21 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
| WO2017007634A1 (en) | 2015-07-06 | 2017-01-12 | The Board Of Regents Of The University Of Texas System | Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers |
| DK3322417T3 (da) | 2015-07-15 | 2023-10-30 | Univ Texas | Målretning af emopamil-bindingsprotein (EBP) med små molekyler, der inducerer et unormalt feedbackrespons ved sænkning af endogen cholesterolsyntese |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| EP3359532A1 (en) | 2015-10-06 | 2018-08-15 | GlaxoSmithKline Intellectual Property Development Limited | Biaryl pyrazoles as nrf2 regulators |
| JP2018529744A (ja) | 2015-10-06 | 2018-10-11 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2レギュレーターとしてのアリールシクロヘキシルピラゾール |
| JP2018535984A (ja) | 2015-11-18 | 2018-12-06 | グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited | リバビリンの医薬組成物 |
| US11833118B2 (en) | 2016-01-20 | 2023-12-05 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
| US10328216B2 (en) | 2016-01-20 | 2019-06-25 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation |
| EP3871717B1 (en) | 2016-05-19 | 2023-11-08 | Trudell Medical International | Smart valved holding chamber |
| US10786638B2 (en) | 2016-07-08 | 2020-09-29 | Trudell Medical International | Nebulizer apparatus and method |
| CA3028604C (en) | 2016-07-08 | 2023-12-05 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| TW201825458A (zh) | 2016-09-20 | 2018-07-16 | 英商葛蘭素史克智慧財產(第二)有限公司 | Trpv4拮抗劑 |
| WO2018055527A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
| KR20190049865A (ko) | 2016-09-20 | 2019-05-09 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Trpv4 길항제 |
| KR20190088404A (ko) | 2016-12-06 | 2019-07-26 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도 |
| WO2018104805A1 (en) | 2016-12-09 | 2018-06-14 | Trudell Medical International | Smart nebulizer |
| JP2020500919A (ja) | 2016-12-12 | 2020-01-16 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2レギュレーターとしての3−カルボン酸ピロール |
| US20200071310A1 (en) | 2016-12-12 | 2020-03-05 | Glaxosmithkline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
| WO2018109647A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl amides as nrf2 regulators |
| US20220002272A1 (en) | 2016-12-14 | 2022-01-06 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl lactams as nrf2 activators |
| EP3555078B1 (en) | 2016-12-14 | 2024-03-27 | GlaxoSmithKline Intellectual Property Development Limited | Bisaryl heterocycles as nrf2 activators |
| ES2908941T3 (es) | 2016-12-15 | 2022-05-04 | Glaxosmithkline Ip Dev Ltd | Triazoles unidos a éter como reguladores de NRF2 |
| US11028099B2 (en) | 2016-12-15 | 2021-06-08 | Glaxosmithkline Intellectual Property Development Limited | NRF2 activators |
| CN108328122B (zh) * | 2017-01-17 | 2024-04-12 | 李和伟 | 一种制剂盒 |
| ES2901875T3 (es) | 2017-04-24 | 2022-03-24 | Cocrystal Pharma Inc | Derivados de la pirrolopirimidina útiles como inhibidores de la replicación del virus de la influenza |
| WO2019116231A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
| JP2021505636A (ja) | 2017-12-11 | 2021-02-18 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのnrf2アクチベーター |
| GB201720989D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| MX2020007026A (es) | 2018-01-04 | 2020-12-03 | Trudell Medical Int | Dispositivo de presión espiratoria positiva oscilante inteligente. |
| IL276013B2 (en) | 2018-01-17 | 2024-03-01 | Glaxosmithkline Ip Dev Ltd | Pi4kiiibeta inhibitors |
| CN108815653B (zh) * | 2018-04-19 | 2020-11-10 | 山西白求恩医院 | 一种气体速度可调节的雾化器 |
| US11643407B2 (en) | 2018-05-23 | 2023-05-09 | Glaxosmithkline Intellectual Property Development Limited | Indanes as NRF2 activators |
| WO2020023813A1 (en) | 2018-07-27 | 2020-01-30 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
| GB201812671D0 (en) | 2018-08-03 | 2018-09-19 | Coalesce Product Dev Ltd | An inhaler device |
| EP3849978B1 (en) | 2018-09-10 | 2022-11-02 | Cocrystal Pharma, Inc. | Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication |
| PT3866778T (pt) | 2018-10-17 | 2023-02-28 | Cocrystal Pharma Inc | Combinações de inibidores da replicação do vírus de la gripe |
| EP3880251B1 (en) | 2018-11-13 | 2025-04-09 | Cocrystal Pharma, Inc. | Formulations of influenza therapeutics |
| US12565488B2 (en) | 2018-11-26 | 2026-03-03 | Cocrystal Pharma, Inc. | Inhibitors of influenza virus replication |
| WO2020135920A1 (en) * | 2018-12-28 | 2020-07-02 | Université Libre de Bruxelles | Kit for inhaled chemotherapy, and treatment of lung cancer with said kit |
| DE102019134285A1 (de) | 2019-01-15 | 2020-07-16 | Nuuvera Deutschland GmbH | Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze |
| CN109939309B (zh) * | 2019-04-01 | 2021-06-01 | 中国科学院大学深圳医院(光明) | 粉状物吸入装置 |
| GB201908536D0 (en) | 2019-06-13 | 2019-07-31 | Glaxosmithkline Ip Dev Ltd | Compounds |
| EP4021542B1 (en) | 2019-08-27 | 2025-07-16 | Trudell Medical International Inc. | Respiratory therapy device comprising a visual feedback array |
| US20230151034A1 (en) | 2020-03-17 | 2023-05-18 | Cocrystal Pharma, Inc. | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication |
| JP7721561B2 (ja) | 2020-04-10 | 2025-08-12 | コクリスタル ファーマ,インコーポレイテッド | ノロウイルス及びコロナウイルス複製の阻害剤 |
| WO2021216547A1 (en) | 2020-04-20 | 2021-10-28 | Sorrento Therapeutics, Inc. | Pulmonary administration of ace2 polypeptides |
| CN112298819A (zh) * | 2020-10-28 | 2021-02-02 | 朱爱庆 | 一种具有防潮功能的定量取药瓶 |
| WO2022175425A1 (en) | 2021-02-22 | 2022-08-25 | Glaxosmithkline Intellectual Property Development Limited | Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection |
| WO2022179967A1 (en) | 2021-02-23 | 2022-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Vadadustat for treating covid-19 in a hospitalized subject |
| WO2022221530A1 (en) | 2021-04-14 | 2022-10-20 | The University Of North Carolina At Chapel Hill | Hot porous-solid metering systems and methods for generation of therapeutic aerosols by evaporation/condensation |
| JP2024530920A (ja) | 2021-08-03 | 2024-08-27 | コクリスタル ファーマ,インコーポレイテッド | コロナウイルスに対する阻害剤 |
| US11517704B1 (en) * | 2021-12-06 | 2022-12-06 | Stat Capsule Inc. | Wristband capsule crusher |
| CN114098624B (zh) * | 2021-12-30 | 2022-09-02 | 山东第一医科大学附属省立医院(山东省立医院) | 一种可视的直肠快速内检装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB516834A (en) * | 1937-12-23 | 1940-01-12 | Charles Alexandre Nicolle | Improvements in or relating to packaging |
| CH385718A (fr) * | 1961-11-04 | 1964-12-15 | Bodet Jean | Procédé et dispositif pour conditionner des articles solides de petit volume, et ensemble obtenu par ce procédé |
| CH411232A (de) * | 1963-11-12 | 1966-04-15 | Ciba Geigy | Arzneimittelverpackung |
| GB1268051A (en) * | 1968-06-07 | 1972-03-22 | Fisons Pharmaceuticals Ltd | Inhalation device |
| DE2321615A1 (de) * | 1973-04-28 | 1974-11-14 | Aluminium Walzwerke Singen | Kindersichere verpackung |
| GB1387954A (en) * | 1973-05-08 | 1975-03-19 | Miles Lab | Insufflator |
| US4015717A (en) * | 1974-03-29 | 1977-04-05 | The Medical Dispenser Company | Tablet package for use in chronologically dispensing tablets |
| YU41046B (en) * | 1974-08-22 | 1986-10-31 | Schering Ag | Medicine inholating device |
| AT337088B (de) * | 1975-05-20 | 1977-06-10 | Desinfecta Ges M B H | Verpackung fur pulver, korner und dgl. und verfahren zu ihrer herstellung |
| GB1562732A (en) * | 1976-02-10 | 1980-03-12 | Allen & Hanburys Ltd | Device for dispensing medicaments |
| DE2716323C2 (de) * | 1977-04-07 | 1986-03-13 | Schering AG, 1000 Berlin und 4709 Bergkamen | Vorrichtung zur Inhalation von Arzneimitteln |
| DE2835122C3 (de) * | 1978-08-10 | 1982-02-18 | Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart | Inhalationsgerät |
| GB2061735B (en) * | 1979-10-30 | 1983-11-30 | Riker Laboratories Inc | Breath actuated device for administration of powdered medicaments by inhalation |
| CY1308A (en) * | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
| BR8007911A (pt) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | Inalador aperfeicoado |
| US4307734A (en) * | 1980-06-23 | 1981-12-29 | B & B Inventors & Marketers, Inc. | Snuff dispenser |
| ES8206980A1 (es) * | 1980-10-30 | 1982-09-01 | Riker Laboratories Inc | Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo |
| DE8218231U1 (de) * | 1982-06-25 | 1982-12-30 | Karl Knauer Gmbh & Co Kg, 7616 Biberach | Schaupackung insbesondere Blisterpackung |
-
1983
- 1983-10-07 NL NL8303461A patent/NL192564C/nl not_active IP Right Cessation
- 1983-10-07 NO NO833667A patent/NO160330C/no not_active IP Right Cessation
- 1983-10-07 DK DK198304643A patent/DK172541B1/da not_active IP Right Cessation
- 1983-10-07 ZW ZW214/83A patent/ZW21483A1/xx unknown
- 1983-10-07 IN IN1243/CAL/83A patent/IN160851B/en unknown
- 1983-10-07 CH CH5469/83A patent/CH662277A5/de not_active IP Right Cessation
- 1983-10-07 NZ NZ205892A patent/NZ205892A/en unknown
- 1983-10-07 BR BR8305562A patent/BR8305562A/pt not_active IP Right Cessation
- 1983-10-07 IT IT49120/83A patent/IT1203660B/it active
- 1983-10-07 FI FI833641A patent/FI79651C/fi not_active IP Right Cessation
- 1983-10-07 ES ES1983286422U patent/ES286422Y/es not_active Expired
- 1983-10-07 CA CA000438678A patent/CA1224992A/en not_active Expired
- 1983-10-07 AU AU19977/83A patent/AU570013B2/en not_active Expired
- 1983-10-07 IL IL69932A patent/IL69932A/xx not_active IP Right Cessation
- 1983-10-07 GR GR72643A patent/GR79615B/el unknown
- 1983-10-07 SE SE8305542A patent/SE458824B/sv not_active IP Right Cessation
- 1983-10-07 LU LU85034A patent/LU85034A1/fr unknown
- 1983-10-07 AT AT0357683A patent/AT396333B/de not_active IP Right Cessation
- 1983-10-07 IE IE2367/83A patent/IE56059B1/en not_active IP Right Cessation
- 1983-10-07 FR FR838316025A patent/FR2550452B1/fr not_active Expired - Lifetime
- 1983-10-07 US US06/540,203 patent/US4627432A/en not_active Expired - Lifetime
- 1983-10-07 PT PT77471A patent/PT77471B/pt unknown
- 1983-10-07 DE DE19833336486 patent/DE3336486A1/de active Granted
- 1983-10-07 GB GB08326878A patent/GB2129691B/en not_active Expired
- 1983-10-08 KR KR1019830004771A patent/KR910002248B1/ko not_active Expired
-
1985
- 1985-03-25 FR FR858504382A patent/FR2570607B1/fr not_active Expired - Lifetime
-
1987
- 1987-12-30 AU AU83155/87A patent/AU584535B2/en not_active Expired
-
1988
- 1988-10-17 SE SE8803702A patent/SE465752B/sv not_active IP Right Cessation
-
1989
- 1989-02-09 SG SG68/89A patent/SG6889G/en unknown
- 1989-02-15 KE KE3860A patent/KE3860A/xx unknown
- 1989-07-21 CY CY1477A patent/CY1477A/en unknown
- 1989-07-21 CY CY1478A patent/CY1478A/en unknown
- 1989-08-24 HK HK677/89A patent/HK67789A/xx not_active IP Right Cessation
-
1991
- 1991-09-26 JP JP3274575A patent/JPH05200100A/ja active Granted
-
1992
- 1992-03-23 JP JP1992015218U patent/JPH0620532Y2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910002248B1 (ko) | 환자용 투약장치 | |
| CA1272917A (en) | Devices for administering medicaments to patients | |
| US4778054A (en) | Pack for administering medicaments to patients | |
| GB2169265A (en) | Pack for medicament | |
| KR910004328B1 (ko) | 투약장치 | |
| CZ288921B6 (cs) | Blistrový kotouč pro inhalátor | |
| CA2569336A1 (en) | Dry powder inhaler | |
| JPS5988158A (ja) | 患者に医薬を投与する装置とそれに使用するパツク | |
| DK173079B1 (da) | Medikamentpakning | |
| FI81255C (fi) | Foerpackning foer anvaendning i inhalationsanordning. | |
| CA1236736A (en) | Device for administering medicament to patients | |
| NL193681C (nl) | Verpakking voor medicamenten. | |
| IE56060B1 (en) | Medicament-containing pack |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PUP | Patent expired |